semaglutide

Does Semaglutide Increase Risk for Optic Neuropathy?

Medscape - 08 Nov 2024
Does Semaglutide Increase Risk for Optic Neuropathy? ...

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

News-Medical.Net - 08 Nov 2024
Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes ...

Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis

nejm.org - 30 Oct 2024
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis ...

Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study”

Futurism - 02 Nov 2024
Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study” ...

Obesity Drug Shows Promise in Easing Knee Osteoarthritis Pain

The New York Times - 01 Nov 2024
Obesity Drug Shows Promise in Easing Knee Osteoarthritis Pain ...

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Nature.com - 25 Oct 2024
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial ...

Semaglutide: What impact does it really have on heart health?

Medical News Today - 20 Oct 2024
Semaglutide: What impact does it really have on heart health? ...

Diabetes Breakthrough: New Treatment Eliminates Insulin for 86% of Patients

SciTechDaily - 17 Oct 2024
Diabetes Breakthrough: New Treatment Eliminates Insulin for 86% of Patients ...

Ozempic’s cousin drug liraglutide is about to get cheaper. But how does it stack up?

The Conversation - 02 Oct 2024
Ozempic’s cousin drug liraglutide is about to get cheaper. But how does it stack up? ...

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

CNN - 06 Nov 2024
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns ...

Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029

GlobeNewswire - 08 Nov 2024
Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029 ...

Does Semaglutide Increase Risk for Optic Neuropathy?

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis

Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study”

Obesity Drug Shows Promise in Easing Knee Osteoarthritis Pain

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Semaglutide: What impact does it really have on heart health?

Diabetes Breakthrough: New Treatment Eliminates Insulin for 86% of Patients

Ozempic’s cousin drug liraglutide is about to get cheaper. But how does it stack up?

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029

Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Semaglutide cuts major kidney complications risk for adults with type 2 diabetes, CKD

Can weight loss drug semaglutide slow down ageing? Here’s looking at its multiple benefits

Has semaglutide transformed treatment of diabetes and obesity in India?

Novo Nordisk reports positive data from part one of semaglutide trial for MASH

How Compounded Semaglutide Helps in Regulating Metabolism

Can Ozempic and Wegovy help reduce knee osteoarthritis-related pain?

What's New

Get in touch